Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Prescription opioids for back pain and use of medications for erectile dysfunction.

Deyo RA, Smith DH, Johnson ES, Tillotson CJ, Donovan M, Yang X, Petrik A, Morasco BJ, Dobscha SK.

Spine (Phila Pa 1976). 2013 May 15;38(11):909-15. doi: 10.1097/BRS.0b013e3182830482.

2.

Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.

Mulhall JP, McLaughlin TP, Harnett JP, Scott B, Burhani S, Russell D.

J Sex Med. 2005 Nov;2(6):848-55.

PMID:
16422809
3.

Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.

Scranton RE, Goldstein I, Stecher VJ.

J Sex Med. 2013 Feb;10(2):551-61. doi: 10.1111/j.1743-6109.2012.02998.x. Epub 2012 Nov 15. Review.

PMID:
23153075
4.

Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active.

[No authors listed]

Harv Health Lett. 2014 May;39(7):7. No abstract available.

PMID:
25073193
5.

Clinical monograph for drug formulary review: erectile dysfunction agents.

Campbell HE.

J Manag Care Pharm. 2005 Mar;11(2):151-71. Review.

6.

Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.

Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A; EDOS Group.

Int J Clin Pract. 2007 Nov;61(11):1850-62. Epub 2007 Sep 10.

7.

Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS).

Martin-Morales A, Haro JM, Beardsworth A, Bertsch J, Kontodimas S; EDOS Group.

Eur Urol. 2007 Feb;51(2):541-50; discussion 550. Epub 2006 Oct 16. Erratum in: Eur Urol. 2007 Jul;52(1):304-6.

PMID:
17084518
8.

The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.

Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A; Endotrial Study Group.

J Sex Med. 2009 Sep;6(9):2547-60. doi: 10.1111/j.1743-6109.2009.01375.x. Epub 2009 Jun 29.

PMID:
19570039
9.

The Global Online Sexuality Survey (GOSS): the United States of America in 2011 chapter II: phosphodiesterase inhibitors utilization among English speakers.

Shaeer O.

J Sex Med. 2013 Feb;10(2):532-40. doi: 10.1111/j.1743-6109.2012.02972.x. Epub 2012 Oct 22.

PMID:
23088586
10.

Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.

Spitzer M, Basaria S, Travison TG, Davda MN, Paley A, Cohen B, Mazer NA, Knapp PE, Hanka S, Lakshman KM, Ulloor J, Zhang A, Orwoll K, Eder R, Collins L, Mohammed N, Rosen RC, DeRogatis L, Bhasin S.

Ann Intern Med. 2012 Nov 20;157(10):681-91. doi: 10.7326/0003-4819-157-10-201211200-00004.

PMID:
23165659
11.

Management of erectile dysfunction in general practice.

De Berardis G, Pellegrini F, Franciosi M, Pamparana F, Morelli P, Tognoni G, Nicolucci A; EDEN Study Group.

J Sex Med. 2009 Apr;6(4):1127-34. doi: 10.1111/j.1743-6109.2008.01093.x. Epub 2008 Dec 5.

PMID:
19138378
13.

Combined testosterone and vardenafil treatment for restoring erectile function in hypogonadal patients who failed to respond to testosterone therapy alone.

Yassin DJ, Yassin AA, Hammerer PG.

J Sex Med. 2014 Feb;11(2):543-52. doi: 10.1111/jsm.12378. Epub 2013 Nov 20.

PMID:
24251448
14.

Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.

Kim E, Seftel A, Goldfischer E, Baygani S, Burns P.

Curr Med Res Opin. 2015 Feb;31(2):379-89. doi: 10.1185/03007995.2014.989317. Epub 2014 Dec 2.

PMID:
25455432
15.

Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study.

Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L, Porto R, Bangerter K, Seger M, Montorsi F; Vardenafil Study Site Investigators.

Am J Psychiatry. 2006 Jan;163(1):79-87.

PMID:
16390893
16.

Comparison of the first intake of vardenafil and tadalafil in patients with diabetic neuropathy and diabetic erectile dysfunction.

Kamenov ZA.

J Sex Med. 2011 Mar;8(3):851-64. doi: 10.1111/j.1743-6109.2010.02148.x. Epub 2010 Dec 8.

PMID:
21143421
18.

Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.

Fusco F, Sicuteri R, Rossi A, Kontodimas S, Haro JM, Imbimbo C, Mirone V; Italian EDOS Study Group.

Asian J Androl. 2009 Sep;11(5):629-37. doi: 10.1038/aja.2009.48. Epub 2009 Aug 24.

19.

Sildenafil or vardenafil nonresponders' erectile response to tadalafil.

Ozgur BC, Gonenc F, Yazicioglu AH.

Urol J. 2009 Fall;6(4):267-71.

20.

New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.

Mason RG.

J R Soc Promot Health. 2003 Jun;123(2):79-80. No abstract available.

PMID:
12852189

Supplemental Content

Support Center